| 摘要 |
The present invention relates to: a method for determining the prognosis of renal failure, characterized by measuring fibroblast growth factor-23 and 25-hydroxy-vitamin-D in a biological sample; and a kit for determining the prognosis of renal failure, characterized by comprising a reagent for measuring fibroblast growth factor-23 and a reagent for measuring 25-hydroxy-vitamin-D. The present invention provides a method for determining the prognosis of renal failure and a kit for determining the prognosis of renal failure, which are useful for the determination of therapeutic strategies including the selection of a medicine to be administered, the employment of a more strict diet therapy and the introduction of a dialysis treatment at an early stage. |
